ライフサイエンスコーパス: fibroblast growth factor-23

1 calcemia, changes in parathyroid hormone, or fibroblast growth factor 23.

2 f 25(OH) vitamin D, parathyroid hormone, and fibroblast growth factor 23.

3 roid hormone, 1,25-dihydroxyvitamin D(3), or fibroblast growth factor 23.

4 phosphate excretion, parathyroid hormone, or fibroblast growth factor-23.

5 Fibroblast growth factor-23, 1,25-(OH)2-vitamin D3, and

6 ed osteomalacia involves tumor expression of fibroblast growth factor 23, a hormone that inhibits pro

7 te, specifically the secretion and action of fibroblast growth factor 23 and parathyroid hormone.

8 e blood of cKO mice had an elevated level of fibroblast growth factor 23 and reduced level of phospho

9 baseline (1990-1992) serum levels of intact fibroblast growth factor-23 and incident ESRD in 13,448

10 d 24,25-dihydroxyvitamin D, decreased intact fibroblast growth factor 23, and elevated inorganic phos

11 ect the elevated plasma levels of osteocytic fibroblast growth factor 23 but decreased the elevated l

12 st growth factor 23 (iFGF23) into C-terminal fibroblast growth factor 23 (cFGF23), elevated levels of

13 Plasma fibroblast growth factor-23 concentration increased afte

14 High-fibroblast growth factor-23 concentration positively cor

15 artery disease, diabetes, dialysis vintage, fibroblast growth factor-23 concentration, and age, wher

16 Levels of intact fibroblast growth factor 23 decreased rapidly during the

17 Serum fibroblast growth factor-23 enhanced (P < 0.01), whereas

18 Both fibroblast growth factor 23 (FGF-23) and asymmetric dime

19 Fibroblast growth factor 23 (FGF-23) and Klotho are secr

20 vel circulating phosphaturic factors such as fibroblast growth factor 23 (FGF-23) and PHEX are respon

21 Mutations in fibroblast growth factor 23 (FGF-23) cause autosomal dom

22 Plasma fibroblast growth factor 23 (FGF-23) concentration, plas

23 Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF-23) enhance phosphate e

24 Fibroblast growth factor 23 (FGF-23) is a hormone that i

25 Fibroblast growth factor 23 (FGF-23) is a phosphorus-reg

26 Fibroblast growth factor 23 (FGF-23) is an endocrine reg

27 gh level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with

28 roid hormone (PTH), 1,25(OH)2D3 (1,25D), and fibroblast growth factor 23 (FGF-23) maintains mineral h

29 Serum phosphate, calcium, and fibroblast growth factor 23 (FGF-23) were up-regulated a

30 The bone-derived hormone fibroblast growth factor-23 (FGF-23) activates complexes

31 kidney disease (CKD) by increased levels of fibroblast growth factor-23 (FGF-23) and parathyroid hor

32 ge-dependent phenotype correlated with serum fibroblast growth factor-23 (FGF-23) and phosphorus leve

33 trations of the phosphate-regulating hormone fibroblast growth factor-23 (FGF-23) are elevated in pat

34 Fibroblast growth factor-23 (FGF-23) inhibits sodium-dep

35 Fibroblast growth factor-23 (FGF-23) is a hormone that p

36 Fibroblast growth factor-23 (FGF-23) is a novel phosphat

37 Fibroblast growth factor-23 (FGF-23) is a phosphate regu

38 Fibroblast growth factor-23 (FGF-23) is one of the circu

39 An elevated level of fibroblast growth factor-23 (FGF-23) is the earliest abn

40 ently, several phosphaturic peptides such as fibroblast growth factor-23 (FGF-23), secreted frizzled

41 hrough cross-talk between RAAS and vitamin D-fibroblast growth factor-23 (FGF-23)-Klotho pathways.

42 ntially mediated by the phosphaturic hormone fibroblast growth factor-23 (FGF-23).

43 ip between repeated measures of vitamin D or fibroblast growth factor 23 (FGF23) and infectious and c

44 morphological, and biochemical phenotypes of fibroblast growth factor 23 (Fgf23) and klotho ablated m

45 There is growing evidence that fibroblast growth factor 23 (FGF23) and Klotho factor pl

46 sphatemic states arising from high levels of fibroblast growth factor 23 (FGF23) are also associated

47 Levels of fibroblast growth factor 23 (FGF23) are elevated in chro

48 The discovery of fibroblast growth factor 23 (FGF23) as a key regulator o

49 The discovery of fibroblast growth factor 23 (FGF23) as the causal factor

50 s of the parathyroid hormone (PTH)-vitamin D-fibroblast growth factor 23 (FGF23) axis, creatinine, an

51 DHR) is unique among the disorders involving Fibroblast growth factor 23 (FGF23) because individuals

52 Fibroblast growth factor 23 (FGF23) decreases 1,25(OH)2D

53 The discovery of fibroblast growth factor 23 (FGF23) has provided a more

54 asma levels of the osteocyte-derived hormone fibroblast growth factor 23 (FGF23) have emerged as a po

55 Circulating levels of fibroblast growth factor 23 (FGF23) increase during the

56 Circulating levels of bone-derived fibroblast growth factor 23 (FGF23) increase early durin

57 Fibroblast growth factor 23 (FGF23) is a phosphaturic fa

58 An increased circulating level of fibroblast growth factor 23 (FGF23) is an independent ri

59 The regulation of the phosphaturic factor fibroblast growth factor 23 (FGF23) is not well understo

60 Fibroblast growth factor 23 (FGF23) is part of a previou

61 l phosphate-wasting associated with elevated fibroblast growth factor 23 (FGF23) levels and normocalc

62 iations between elevated serum phosphate and fibroblast growth factor 23 (FGF23) levels and risks of

63 Elevated fibroblast growth factor 23 (FGF23) levels, measured at

64 The recognition of fibroblast growth factor 23 (FGF23), a phosphaturic horm

65 ,25(OH)2D3 (1,25D), parathyroid hormone, and fibroblast growth factor 23 (FGF23), and their interacti

66 egulator of the phosphate-regulating hormone fibroblast growth factor 23 (FGF23), because humans with

67 Membrane-bound Klotho binds fibroblast growth factor 23 (FGF23), but a soluble form

68 nd related hormones, parathyroid hormone and fibroblast growth factor 23 (FGF23), on cardiac remodeli

69 1), the calcium-sensing receptor (CASR), and fibroblast growth factor 23 (FGF23), proteins that contr

70 Fibroblast growth factor 23 (FGF23), uncarboxylated matr

71 unique basal and parathyroid hormone (PTH)-, fibroblast growth factor 23 (FGF23)-, and 1,25(OH)2D3-me

72 n (mKL) and recognized as the coreceptor for fibroblast growth factor-23 (FGF23) and a circulating so

73 Fibroblast growth factor-23 (FGF23) induces phosphaturia

74 Fibroblast growth factor-23 (FGF23), a hormone central t

75 low serum vitamin D levels, increased serum fibroblast growth factor-23 (Fgf23), and osteomalacia.

76 ated longitudinal changes in serum levels of fibroblast growth factor-23 (FGF23), parathyroid hormone

77 ny of which are similar to those observed in fibroblast growth factor-23 (FGF23)-deficient mice.

78 , including elevated serum concentrations of fibroblast growth factor-23 (FGF23).

79 cholecalciferol on blood pressure and serum fibroblast growth factor-23 (FGF23).

80 hosphaturic and vitamin D-regulating hormone fibroblast growth factor-23 (FGF23).

81 D promotes production and cleavage of intact fibroblast growth factor 23 (iFGF23) into C-terminal fib

82 Fibroblast growth factor-23 is a bone-derived hormone th

83 imed to assess the effect of paricalcitol on fibroblast growth factor-23/KLOTHO axis in renal transpl

84 rminal pro-B-type natriuretic peptide level, fibroblast growth factor 23 level, estimated glomerular

85 Phosphate binder therapy restored plasma fibroblast growth factor 23 levels but had no effect on

86 d not significantly affect plasma C-terminal fibroblast growth factor 23 levels.

87 ad range of kidney function, higher baseline fibroblast growth factor-23 levels were associated with

88 rus levels, circulating phosphaturic hormone fibroblast growth factor-23 levels, and heart mass.

89 Recent studies suggest that fibroblast growth factor-23 may be an early biomarker of

90 diator of pathologic cardiac remodeling, and fibroblast growth factor-23 may contribute to cardiac re

91 Fibroblast growth factor 23 null mice (Fgf-23-/-) have a

92 ion did not affect serum calcium, phosphate, fibroblast growth factor-23, or alkaline phosphatase lev

93 r KTx: the aortic calcification index (ACI), fibroblast growth factor 23, osteoprotegerin (OPG), fetu

94 ns of certain molecules, such as phosphates, fibroblast growth factor 23, parathyroid hormone, sclero

95 d markers of mineral metabolism, the highest fibroblast growth factor-23 quintile (>54.6 pg/ml) compa

96 Bone-derived FGF-23 (fibroblast growth factor-23) regulates phosphate homeost

97 ake stimulates parathyroid hormone (PTH) and fibroblast growth factor-23 secretion, increasing phosph

98 ighted the effect of phosphate depletion and fibroblast growth factor-23 suppression on the developme

99 Fibroblast growth factor 23, ucMGP, and fetuin-A concent

100 pass renal clearance of parathyroid hormone, fibroblast growth factor 23, vitamin D metabolites, and

101 Elevated fibroblast growth factor 23 was independently associated

102 The renal extraction of fibroblast growth factor 23 was, on average, lower than

103 sphorus, calcitriol, parathyroid hormone, or fibroblast growth factor-23 were not consistently associ

104 ced intact parathyroid hormone and increased fibroblast growth factor-23, with a trend to increase in